Epirubicin, Cisplatin and Continuous-Infusion 5-Fluorouracil (ECF Regimen) in the Treatment of Advanced Colorectal Cancer

Publisher： Karger

E-ISSN： 1421-9794|47|6|438-443

ISSN： 0009-3157

Source： Chemotherapy, Vol.47, Iss.6, 2002-01, pp. : 438-443

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro Models of a Three-Drug Regimen (Epirubicin, Cisplatin and Fluorouracil) for the Treatment of Colorectal Cancer

By  

Chemotherapy, Vol. 47, Iss. 6, 2002-01 ,pp. : 430-437

Karger

Access to resources Recommend Favorite

Bimonthly Regimen of High-Dose Leucovorin, Infusional 5-Fluorouracil, Epirubicin and Cisplatin (Modified ECF) as Adjuvant Chemotherapy in Resected Gastric Adenocarcinoma

By  

Chemotherapy, Vol. 58, Iss. 3, 2012-07 ,pp. : 233-240

Karger

Access to resources Recommend Favorite

Retrospective Analysis of the Risk Factors for Grade IV Neutropenia in Oesophageal Cancer Patients Treated with a Docetaxel, Cisplatin, and 5-Fluorouracil Regimen

By  

Chemotherapy, Vol. 62, Iss. 4, 2017-04 ,pp. : 215-224

Karger

Access to resources Recommend Favorite

Comparison of Cisplatin-5-Fluorouracil-Folinic Acid versus Modified Docetaxel-Cisplatin-5-Fluorouracil Regimens in the First-Line Treatment of Metastatic Gastric Cancer

By  

Chemotherapy, Vol. 57, Iss. 3, 2011-05 ,pp. : 230-235

Karger

Access to resources Recommend Favorite

Comparison of a 48-Hour Infusion of 5-Fluorouracil without Folinic Acid with 24-Hour Folinic Acid/5-Fluorouracil in Patients with Metastatic Colorectal Cancer Refractory to Bolus Folinic Acid/5-Fluorouracil

By  

Chemotherapy, Vol. 49, Iss. 1-2, 2003-05 ,pp. : 85-89

Karger

Access to resources Recommend Favorite